Phase III trial of GSK 961081 monotherapy in patients with chronic obstructive pulmonary disease.
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2013
At a glance
- Drugs Batefenterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- 25 Jul 2013 This trial will not be initiated in 2013, according to a Theravance media release.
- 06 May 2013 This trial is expected to be initiated in 2013, according to a Theravance media release.
- 06 May 2013 New trial record